| DC Field | Value | Language |
|---|
| dc.contributor.author | Lukyanova, Y. S. | - |
| dc.contributor.author | Kolesnichenko, P. D. | - |
| dc.contributor.author | Gureev, V. V. | - |
| dc.contributor.author | Zhilinkova, L. A. | - |
| dc.date.accessioned | 2022-04-26T06:32:03Z | - |
| dc.date.available | 2022-04-26T06:32:03Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Evaluation of pharmacological correction of L-NAME-induced endothelial dysfunction, platelet aggregation and venous tone with diosmin detralex 1000 mg / Y.S. Lukyanova [et al.] // Research Results in Pharmacology. - 2018. - Vol. 4, № 4.- P. 21-27. - Doi: 10.3897/rrpharmacology.4.31748. - Refer.: p. 26-27. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46341 | - |
| dc.description.abstract | Chronic venous diseases are one of the urgent problems of modern medicine. Recent studies have shown high significance of endothelial dysfunction (ED) and oxidative stress in their pathogenesis. For the correction of the occurring changes, drugs of the flavonoid group, particularly diosmin and hesperidin, are currently used | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | platelet aggregation | ru |
| dc.subject | vein-specific inflammation | ru |
| dc.subject | detralex | ru |
| dc.subject | diosmin | ru |
| dc.subject | chronic venous insufficiency | ru |
| dc.subject | endothelial dysfunction | ru |
| dc.title | Evaluation of pharmacological correction of L-NAME-induced endothelial dysfunction, platelet aggregation and venous tone with diosmin detralex 1000 mg | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 4, № 4
|
